This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Mirati Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jacob Haling: Innovator in Cancer Treatment
Introduction
Jacob Haling is a notable inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on combination therapies aimed at treating KRas G12C cancers, which are known for their challenging nature and resistance to conventional therapies.
Latest Patents
Jacob Haling holds a patent related to combination therapies for treating KRas G12C cancers. The patent outlines methods of treating cancer in a subject in need thereof, comprising administering a therapeutically effective amount of a combination of a SOS1 inhibitor and a KRas G12C inhibitor. This invention also includes pharmaceutical compositions, kits comprising such compositions, and methods of use for these therapies. He has 1 patent to his name.
Career Highlights
Jacob Haling is currently associated with Mirati Therapeutics, Inc., a company dedicated to developing innovative therapies for cancer treatment. His work at Mirati Therapeutics has positioned him as a key player in the advancement of targeted cancer therapies.
Collaborations
Jacob has collaborated with notable colleagues, including John Michael Ketcham and Shilpi Khare, who share his commitment to advancing cancer treatment through innovative research and development.
Conclusion
Jacob Haling's contributions to the field of cancer treatment through his innovative patent on combination therapies highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the fight against cancer.